Alaris Royalty Corp. Releases Q4 2017 Financial Results

NOT FOR DISTRIBUTION IN THE UNITED STATES. 

FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW.

CALGARY, Alberta, March 05, 2018 (GLOBE NEWSWIRE) -- Alaris Royalty Corp. (“Alaris” or the "Corporation") is pleased to announce its results for the three and twelve months ended December 31, 2017. The results are prepared under International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”).

2017 Highlights:

  • Total capital deployment of over CAD$172 million funded through internally generated cash flow (CAD$125 million through cash flow from operations and proceeds on redemption of units) into three new partners and four follow on transaction with current Partners:
    • USD$85.0 million into Sales Benchmark Index, LLC (“SBI”)
    • USD$20.0 million into Accscient, LLC (“Accscient”)
    • USD$6.2 million into ccCommunications, LLC (“ccComm”) in two tranches
    • USD$13.5 million into Federal Resources Supply Company (“FED”)
    • USD$13.0 million into Sandbox Acquisitions, LLC (“Sandbox”) in two tranches
  • Recorded a significant gain on redemption of the units in Sequel Youth and Family Services, LLC (“Sequel”) as a result of the sale of Sequel to a third party. The Corporation contributed USD$73.5 million and received USD$95.6 million on exit in addition to the USD$47.2 million in distributions received resulting in a gain of USD$21.7 million and an IRR of 29% (CAD);
  • Recorded revenue from Partners of $89.0 million, $2.44 per share, a decrease from 2016 ($100.0 million, $2.75 per share) due to partner redemptions in the past twenty-four months ($17.6 million) and the non-payment or partial payment of distributions from three existing partners for a net decrease of $11.1 million, partially offset by new partner distributions in 2017 of $13.2 million and higher distributions from positive resets ($3.6 million).

  • Recorded Normalized EBITDA of $76.9 million, $2.11 per share, a decrease from the prior year ($81.8 million, $2.25 per share) as the decrease in distributions (as noted above) was partially offset from lower G&A and variable compensation.

  • Paid $59 million in dividends, an actual payout ratio of 87.6%

  • Significant events subsequent to year end included:
    • A US$15 million contribution to another new partner in Heritage Restoration Inc.;
    • A vote of confidence from the Corporation’s senior lenders with the increase of the senior credit facility from $200 million to $280 million and an increase of the maximum leverage covenant from 1.75x to 2.5x; and
    • A successful conclusion and redemption of the Agility Health, LLC units at a premium to the cost and book value as well as the collection of all unpaid distributions resulting in an IRR of 25% (CAD, assuming the escrowed amount is paid in full) during the five year term of the investment.

Presidents Message

2017 was a dynamic year within Alaris’ portfolio.  In addition to setting a new record for capital deployment over the last twelve months and adding the single largest partner in our history, we also continued our strong track record of returns on partners where we have sold alongside the entrepreneur.  Over the 14 year history of Alaris, we have now had a full investment cycle with 10 companies (including the recently announced Agility transaction) and have recorded internal rates of return of greater than 20% in seven of them with a weighted average of roughly 17.5%.  Management believes these results put us near the top of our industry in performance. 

Most encouraging is the strength of our current portfolio. Alongside progress from companies that have experienced challenges, our largest partners continue to be amongst our best performers and more than 80% of our revenue in 2017 is from partners that are growing their distributions to us year over year.  Of the challenged files, we were able to successfully exit Agility with an IRR of 25% and we re-instituted partial distributions from SCR in 2017 and expect those distributions to increase this year. Partial Kimco distributions are expected to re-start imminently with the recent change in the company’s banking relationship and improving financial results.  Group SM was the one major disappointment in 2017 but discussions to recoup our remaining outstanding debt have been encouraging.  As a whole, we are pleased with the performance but will as always continue to explore ways to improve our performance. Utilizing innovative structures that have been initiated over the last few years we believe will have measurable benefits for our shareholders moving forward.

Looking ahead, while the overall environment in the private equity industry remains extremely competitive, we do see an opportunity to continue growing our capital deployment due to increasing interest rates in the US, restrictions on the use of high levels of debt and also our own new initiatives.  Shareholders can expect to see Alaris invest not just with our traditional preferred shares in our partners but also with a small amount of common shares that will provide us with additional upside on successful partners while also allowing us to participate in additional transactions where more than just preferred shares are required to compete.  This small change will not change the mission of Alaris to provide our shareholders with a safe, predictable cash dividend stream that we’ve been delivering since we started in early 2004 but we do feel that it will enhance our ability to deploy more capital with highly accretive returns.

I look forward to reporting back in one year’s time after what we expect to be another very successful year. 

       
Per Share ResultsThree Months Ended Year ended
Period ending December 31 2017 2016% Change 2017 2016% Change
Revenue per share$0.59$0.75-21.3%$2.44$2.75-11.3%
Normalized EBITDA per share$0.51$0.54-5.6%$2.11$2.25-6.2%
Net cash from operating activities per share$0.55$0.86-36.0%$1.85$2.02-8.4%
Dividends per share$0.405$0.405+0.0%$1.62$1.62+0.0%
Basic earnings per share$0.31$0.60-48.3%$0.33$1.83-82.0%
Fully diluted earnings per share$0.31$0.59-47.5%$0.32$1.81-82.3%
Normalized basic earnings per share$0.58$0.64-9.4%$1.81$1.75+3.4%
Weighted average basic shares outstanding (000’s) 36,464 36,365  36,447 36,336 
       

1Using the weighted average shares outstanding for the period.

The Corporation recorded earnings of $11.9 million, EBITDA of $29.0 million and Normalized EBITDA of $77.0 million for the year ended December 31, 2017 compared to earnings of $66.6 million, EBITDA of $92.3 million and Normalized EBITDA of $81.8 million for the year ended December 31, 2016. The -5.9% decrease in Normalized EBITDA is a result of redemptions as discussed above (LifeMark, Solowave, MAHC and Sequel) and reduced or no distributions from existing partners (SCR, Group SM, Kimco), offset by distributions from new partners (SBI, Accscient, ccComm, Unify and follow on transactions with Sandbox and Federal Resources), net positive resets and lower corporate costs.

The decrease in earnings is a result of lower revenue (or distribution from partners) in 2017, $42.5 million of impairment & other charges related mostly to Group SM, bad debt expense on unpaid distributions ($9.8 million) and a reserve on the unsecured promissory note ($5.4 million) from Group SM, a $0.5 million bad debt expense on the SHS promissory note, a $1.5 million discount and $5.1 million bad debt provision on the Phoenix promissory note (a note held by Phoenix Holdings Limited a company controlled by the former principals of KMH), a $2.6 million reserve on the Kimco long term accounts receivable and promissory note, $10.3 million of taxes and $10.6 million non-cash unrealized loss on foreign exchange items, partially offset by $26.7 million from the redemption of Sequel Units and a $1.4 million realized foreign exchange gain. The comparable period included a $20.3 million gain on the redemption of LifeMark, Solowave and MAHC units (including $5.3 million in additional distributions on redemption), partially offset by a $7.0 million impairment of KMH units and a $2.4 million bad debt related to KMH distributions and an allowance for Kimco long-term receivable.  

The redemption of Sequel was the ninth exit event (seven with positive returns, two with negative) in the Corporation’s history and adds to an impressive track record where on CAD$350 million invested, the Corporation has received CAD$420 in exit proceeds in addition to CAD$214 million in annual distributions. Of note, in only one of those nine exits was Alaris refinanced – most redemptions occurring as a result of the sale of the underlying business. The details of each exit event are available in the Corporate Presentation available on Alaris’ website. 

     
Reconciliation of Net Income to EBITDA Three months ended December 31Year  ended December 31
in thousands 2017  2016  2017  2016 
Earnings $   11,410  $  21,645  $  11,882  $  66,553  
Adjustments to Net Income:    
Amortization and depreciation   67    71    268    279 
Finance costs   1,575    1,483    6,582    5,882 
Income tax expense   (4,964)   5,249    10,274    19,589 
EBITDA   8,088     28,448     29,006     92,303  
Normalizing Adjustments    
Gain on disposal of investment   -     (94)   (26,575)   (20,271)
Impairment and other charges   -     -     42,491    7,000 
Bad Debt Expense   13,617    1,589    23,430    2,442 
Distributions received on redemption (MAHC)   -     (5,318)   -     (5,318)
Unrealized (gain) / loss on foreign exchange   (2,081)   149    10,649    8,502 
Realized (gain) on foreign exchange   (852)   (5,227)   (1,370)   (3,473)
Penalties and Fees   (502)   -     (502)   656 
Accretion of prom. notes & other receivables   252    -     (150)   -  
Normalized EBITDA$  18,523  $  19,547  $  76,979  $  81,842  
     


     
Normalized EarningsThree months ended December 31Year ended December 31
in thousands except on per share basis 2017  2016  2017  2016 
Earnings before the undernoted$  5,940 $  28,526 $  39,386 $  100,526 
Finance costs   (1,575)   (1,483)   (6,582)   (5,882)
Impairment and other charges   -     -     42,491    7,000 
Bad debt expense & reserve   13,617    1,589    23,430    2,442 
(Gain)/Loss on redemption   -     (94)   (26,575)   (20,271)
Normalized Earnings pre-tax$  17,982  $  28,538  $  72,150  $  83,816  
Total income taxes   4,964    (5,249)   (10,274)   (19,589)
Tax normalizations for above items   (1,911)   (67)   4,246    (509)
Normalized Earnings$  21,035  $  23,222  $  66,122  $  63,718  
Normalized Earnings per share   
Basic$0.58 $0.64 $1.81 $1.75 
Fully diluted $0.57 $0.63 $1.80 $1.74 

“The overall performance of the portfolio in 2017 was exceptional as demonstrated by approximately $2.5 million CAD in performance resets to the annual distributions effective January 1, 2018 and nothing but increases to the fair value of our investments in the fourth quarter. Since the disappointment on the Group SM file in Q3, we have seen continued and measurable progress on other fronts including the recent successful redemption of Agility, and improved financial performance leading to the expected restart of partial distributions for Kimco and an expected increase in the monthly distributions from SCR”, said Darren Driscoll, Chief Financial Officer.

Outlook

Based on Alaris’ current agreements with its partners, it expects revenues of approximately $94 million for 2018 (lower than our previous outlook due to the redemption of the Agility units), revenue for Kimco (currently nil) and SCR ($100 thousand per month) are included at their current run rate, however the Corporation expects distributions from both partners to exceed the included amount. Total revenue from partners is expected to be $23.5 million in Q1 2018, an increase of 9% compared to $21.6 million in Q4 2017.  Annual general and administrative expenses are currently estimated at $8.5 million and include all public company costs.  

Including the successful redemption of Agility, the Corporation’s Annualized Payout Ratio is now just over 90%. The table below sets out our estimated annualized current run rate of net cash from operating activities alongside the after-tax impact of the various improvements the Corporation is expecting in 2018.

    
Annualized Cash Flow (in 000's)CommentsAmount ($)
 $ / Share
 
Revenue$1.30 USD/CAD exchange rate$  94,200 $  2.58 
General & Admins.    (8,500)   (0.23)
Interest & Taxes    (22,000)   (0.60)
Net cash flow  $  63,700     1.75 
Annual Dividend    59,000    1.62 
Surplus / (Shortfall) $  4,700     0.13  
    
Other Considerations:   
SCR & KimcoEvery addtl $2 million in distributions received is $0.05/share +1,600  +0.05 
New InvestmentsEvery $20 million deployed @ 15% +1,515  +0.04 
    

The senior debt facility was drawn to $173.5 million at December 31, 2017, the Corporation used the proceeds from the Agility redemption to reduce the debt facility to $139.5 million subsequent to December 31, 2017, with the capacity to draw up to another $136.2 million based on new covenants and credit terms, in addition to the $70 million accordion facility for a total of $206.2 million. The annual interest rate on that debt was approximately 5.3% at December 31, 2017, increased by 0.25% effective January 2018.

The Consolidated Statement of Financial Position, Statement of Comprehensive Income, and Statement of Cash Flows are attached to this news release. Alaris’ financial statements and MD&A are available on SEDAR at www.sedar.com and on our website at www.alarisroyalty.com.

About the Corporation:
Alaris provides alternative financing to private companies (“Partners”) in exchange for royalties or distributions with the principal objective of generating stable and predictable cash flows for dividend payments to its shareholders.  Distributions from the Partners are adjusted annually based on the percentage change of a “top-line” financial performance measure such as gross margin or same store sales and rank in priority to the owner’s common equity position.

Non-IFRS Measures
The terms EBITDA, Normalized EBITDA and Annualized Payout Ratio are financial measures used in this news release that are not standard measures under International Financial Reporting Standards (“IFRS”). The Corporation’s method of calculating EBITDA, Normalized EBITDA and Annualized Payout ratio may differ from the methods used by other issuers. Therefore, the Corporation’s EBITDA, Normalized EBITDA and Annualized Payout Ratio may not be comparable to similar measures presented by other issuers.

Annualized Payout Ratio:  Annualized payout ratio refers to Alaris’ total annualized dividend per share expected to be paid over the next twelve months divided by the estimated net cash from operating activities per share Alaris expects to generate over the same twelve-month period (after giving effect to the impact of all information disclosed as of the date of this report).

EBITDA refers to net earnings (loss) determined in accordance with IFRS, before depreciation and amortization, net of gain or loss on disposal of capital assets, interest expense and income tax expense. EBITDA is used by management and many investors to determine the ability of an issuer to generate cash from operations. Management believes EBITDA is a useful supplemental measure from which to determine the Corporation’s ability to generate cash available for debt service, working capital, capital expenditures, income taxes and dividends. The Corporation has provided a reconciliation of net income to EBITDA in this news release.

Normalized EBITDA refers to EBITDA excluding items that are non-recurring in nature and is calculated by adjusting for non-recurring expenses and gains to EBITDA.  Management deems non-recurring items to be unusual and/or infrequent items that the Corporation incurs outside of its common day-to-day operations. For the years ended December 31, 2017 and 2016, the gains on the redemption of the LifeMark, Solowave, MAHC and Sequel units, the impairment of the KMH and Group SM units, the write off of the interest on the KMH promissory notes, bad debt expense related to unpaid distributions from Group SM, the impairment and accretion of the Phoenix secured note, bad debt expense of the Kimco long-term receivable and promissory note, one-time penalties and fees related to the CRA GST audit (and the subsequent recovered amount) are considered by management to be non-recurring charges. Foreign exchange realized and unrealized gains and losses are recurring but not considered part of operating results and excluded from EBITDA on an ongoing basis.  Adjusting for these non-recurring items allows management to assess EBITDA from ongoing operations.

Normalized Earnings refers to earnings excluding items that are non-recurring in nature and is calculated by adjusting for non-recurring expenses, gains, non-cash unrealized gains and losses on foreign exchange items and the net tax impact of the adjustments to earnings. Management deems non-recurring items to be unusual and/or infrequent items that the Corporation incurs outside of its common day-to-day operations. The corresponding tax impact of the all non-recurring items is adjusted in Normalized Earnings. For the year ended December 31, 2017 and 2016, the gain on the redemption of the LifeMark, Solowave, MAHC and Sequel units, the impairment of the KMH and Group SM units, the write off of the interest on the Phoenix promissory notes, bad debt expense of the Kimco long-term receivable and promissory note, bad debt expense related to unpaid distributions from Group SM, the impairment and accretion of the Phoenix secured note are considered by management to be non-recurring charges. Foreign exchange realized and unrealized gains and losses are recurring but not considered part of operating results and excluded from earnings on an ongoing basis.  

IRR refers to the annualized effective compounded rate of return on an investment.  Alaris calculates IRR by using all cash outlays (contributions) and inflows (monthly distributions and gross proceeds from redemptions) over the specific time period in which Alaris was invested in a company, on a pre-tax basis.

The terms EBITDA and Normalized EBITDA should only be used in conjunction with the Corporation’s annual audited and quarterly reviewed financial statements, excerpts of which are available below, while complete versions are available on SEDAR at www.sedar.com.

Forward-Looking Statements
This news release contains forward-looking statements under applicable securities laws. Statements other than statements of historical fact contained in this news release are forward‑looking statements, including, without limitation, management's expectations, intentions and beliefs concerning the growth, results of operations, performance of the Corporation and the Private Company Partners, the future financial position or results of the Corporation, business strategy, and plans and objectives of or involving the Corporation or the Partners.  Many of these statements can be identified by looking for words such as "believe", "expects", "will", "intends", "projects", "anticipates", "estimates", "continues" or similar words or the negative thereof. In particular, this news release contains forward‑looking statements regarding: the anticipated financial and operating performance of the Partners in 2018; the revenues/contractual distributions to be received by Alaris in 2018 (annually and quarterly); the Annualized Payout Ratio, the Corporation’s general and administrative expenses in 2018, the expected increase in partner distributions as a result of performance metric resets effective January 1, 2018; the Corporation’s ability to deploy capital; run rate cash from operating activities;  the cash requirements of the Corporation in 2018; the expected restart of distributions from Kimco; expected increase in distributions from SCR; and changes to our investment structure (including using common shares) and the impact therof. To the extent any forward-looking statements herein constitute a financial outlook, including estimates regarding revenues, net cash from operating activities and expenses, they were approved by management as of the date hereof and have been included to provide an understanding with respect to Alaris' financial performance and are subject to the same risks and assumptions disclosed herein. There can be no assurance that the plans, intentions or expectations upon which these forward looking statements are based will occur.

By their nature, forward-looking statements require Alaris to make assumptions and are subject to inherent risks and uncertainties.  Assumptions about the performance of the Canadian and U.S. economies in 2018 and how that will affect Alaris’ business and that of its Partners are material factors considered by Alaris management when setting the outlook for Alaris.  Key assumptions include, but are not limited to, assumptions that the Canadian and U.S. economies will grow moderately in 2018, that interest rates will not rise in a material way over the next 12 to 24 months, that the Partners will continue to make distributions to Alaris as and when required, that the businesses of the Partners will continue to grow, that the Corporation will experience net positive resets to its annual royalties and distributions from its Partners in 2018, more private companies will require access to alternative sources of capital, and that Alaris will have the ability to raise required equity and/or debt financing on acceptable terms.  Management of Alaris has also assumed that capital markets will remain stable and that the Canadian and U.S. dollar trading pair will remain in a range of approximately plus or minus 10% over the next 6 months.  In determining expectations for economic growth, management of Alaris primarily considers historical economic data provided by the Canadian and U.S. governments and their agencies.

There can be no assurance that the assumptions, plans, intentions or expectations upon which these forward‑looking statements are based will occur.  Forward‑looking statements are subject to risks, uncertainties and assumptions and should not be read as guarantees or assurances of future performance. The actual results of the Corporation and the Partners could materially differ from those anticipated in the forward‑looking statements contained herein as a result of certain risk factors, including, but not limited to, the following: the dependence of Alaris on the Partners; reliance on key personnel; general economic conditions; failure to complete or realize the anticipated benefit of Alaris’ financing arrangements with the Partners; a failure to obtain required regulatory approvals on a timely basis or at all; changes in legislation and regulations and the interpretations thereof; risks relating to the Partners and their businesses, including, without limitation, a material change in the operations of a Partner or the industries they operate in; inability to close additional Partner contributions in a timely fashion, or at all; a change in the ability of the Partners to continue to pay Alaris’ preferred distributions; a change in the unaudited information provided to the Corporation; and a failure to realize the benefits of any concessions or relief measures provided by Alaris to any Partner.  Additional risks that may cause actual results to vary from those indicated are discussed under the heading “Risk Factors” and “Forward Looking Statements” in the Corporation’s Management Discussion and Analysis for the year ended December 31, 2017, which is filed under the Corporation’s profile at www.sedar.com and on its website at www.alarisroyalty.com.  Accordingly, readers are cautioned not to place undue reliance on any forward-looking information contained in this news release.  Statements containing forward‑looking information reflect management's current beliefs and assumptions based on information in its possession on the date of this news release.  Although management believes that the expectations represented in such forward‑looking statements are reasonable, there can be no assurance that such expectations will prove to be correct.

For more information please contact:

Curtis Krawetz
Vice President, Investments and Investor Relations
Alaris Royalty Corp.
403-221-7305

Alaris Royalty Corp.  
Consolidated statement of financial position  
   
 31-Dec31-Dec
  2017  2016 
Assets  
Cash and cash equivalents$35,475 $29,491 
Prepayments 2,407  2,097 
Foreign exchange contracts   1,430    -  
Trade and other receivables 8,642  16,762 
Investment tax credit receivable 2,957  3,654 
Promissory notes receivable 15,403  21,922 
Current Assets 66,315  73,926 
Promissory notes and other receivables 32,017  7,891 
Deposits 19,252  16,256 
Equipment 503  647 
Intangible assets 6,116  6,206 
Investments at fair value 669,216  681,093 
Investment tax credit receivable   -   1,201 
Non-current assets 727,103  713,295 
Total Assets$ 793,418  $ 787,221  
   
Liabilities  
Accounts payable and accrued liabilities$1,707 $3,057 
Dividends payable 4,921  4,905 
Foreign exchange contracts   -   712 
Income tax payable   588  2,007 
Current Liabilities 7,217  10,682 
Deferred income taxes 8,192  22,458 
Loans and borrowings 173,464  99,383 
Non-current liabilities 181,656  121,841 
Total Liabilities$ 188,873  $ 132,523  
   
Equity  
Share capital$620,842 $617,893 
Equity reserve 12,058  11,628 
Fair value reserve (17,036) (27,931)
Translation reserve 5,767  23,029 
Retained earnings / (deficit) (17,087)   30,079 
Total Equity$ 604,545  $ 654,698  
   
Total Liabilities and Equity$ 793,418  $ 787,221  
   


Alaris Royalty Corp.  
Consolidated statement of comprehensive income / loss  
For the year ended December 31  
   
 Year ended December 31
  2017  2016 
Revenues  
Royalties and distributions$86,684 $98,486 
Interest and other 2,389  1,556 
Total Revenue 89,073  100,042 
   
Other income  
Gain on partner redemptions   26,575    20,271 
Realized gain on foreign exchange contracts   1,370    3,473 
Total other income   27,945    23,744 
   
Salaries and benefits   3,371    3,361 
Corporate and office   2,597    3,297 
Legal and accounting fees   2,096    2,513 
Non-cash stock-based compensation   3,379    4,369 
Bad debt expense & reserve   23,430    2,442 
Impairment and other charges   42,491    7,000 
Depreciation and amortization   268    279 
Total Operating Expenses   77,632    23,260 
Earnings before the undernoted   39,386     100,526  
Finance costs   6,582    5,882 
Unrealized (gain) on foreign exchange contracts   (2,144)   (4,633)
Unrealized foreign exchange loss   12,793    13,136 
Earnings before taxes   22,155    86,142 
Current income tax expense   22,089    7,104 
Deferred income tax expense / (recovery)   (11,815)   12,484 
Total income tax expense   10,274    19,589 
Earnings   11,882     66,553  
   
Other comprehensive income  
Transfer on redemption of investments at fair value$  (9,062)$  (27,399)
Transfer from fair value reserve to impairment and other charges   4,250    - 
Net change in fair value of investments at fair value   16,692    (8,020)
Tax effect of items in other comprehensive income   (984)   5,613 
Foreign currency translation differences   (17,262)   (4,622)
Other comprehensive (loss) for the year net of income tax   (6,366)   (34,428)
Total comprehensive income for the year$  5,516  $  32,125  
   
Earnings per share  
Basic$0.33 $1.83 
Fully diluted $0.32 $1.81 
Weighted average shares outstanding 
Basic  36,447  36,336 
Fully Diluted  36,754  36,711 
   


Alaris Royalty Corp.  
Consolidated statement of cash flows  
For the year ended December 31  
   
  2017  2016 
Cash flows from operating activities  
Earnings from the year$  11,882 $  66,553 
Adjustments for:  
Finance costs   6,582    5,882 
Deferred income tax expense / (recovery)   (11,815)   12,484 
Depreciation and amortization   268    279 
Bad debt expense & reserve   23,430    2,442 
Impairment and other charges   42,491    7,000 
Gain on partner redemptions, net of cash taxes   (10,535)   (20,271)
Unrealized (gain) on foreign exchange contracts   (2,144)   (4,633)
Unrealized foreign exchange loss   12,793    13,136 
Non-cash stock-based compensation   3,379    4,369 
 $  76,331 $  87,241 
Change in:  
- trade and other receivables   (1,693)   (13,018)
- income tax receivable / payable   319    3,694 
- prepayments   227    337 
- accounts payable and accrued liabilities   (1,350)   919 
Cash generated from operating activities   73,834    79,174 
Finance costs   (6,582)   (5,882)
Net cash from operating activities$  67,252 $  73,292 
   
Cash flows from investing activities  
Acquisition of equipment$  (32)$  (43)
Acquisition of preferred units   (175,293)   (110,882)
Proceeds from partner redemptions, net of cash taxes   116,277    103,212 
Promissory notes issued   (16,467)   (6,750)
Promissory notes repaid   617    313 
Net cash used in investing activities$  (74,899)$  (14,151)
   
Cash flows from financing activities  
Repayment of debt$  (116,277)$  (78,863)
Proceeds from debt   196,528    99,657 
Dividends paid   (59,032)   (58,838)
Deposits with CRA   (2,422)   (4,233)
Net cash from / (used in) financing activities$  18,797 $  (42,278)
   
Net increase in cash and cash equivalents$  11,151 $  16,863 
Impact of foreign exchange on cash balances   (5,166)   (8,363)
Cash and cash equivalents, Beginning of year   29,491    20,991 
Cash and cash equivalents, End of year$  35,475 $  29,491 
 
Cash taxes paid$  26,712 $  7,900 
   

Back to News